ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269599; 2) Community: the network communities that were significantly associated with the response to NSC 269599; 3) Molecule: the relationships between components within communities and NSC 269599; 4) MDR: the compounds that were significantly associated with the NSC 269599.

NSC Compound Enrichment Correlation
NSC 668281 (-)-.beta.-L-1-[(2-Hydroxymethyl)-1,3-dioxolan-4yl]cytosine 0.0421163101172308 0.051036502
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 0.0421163101172308 0.018274199
NSC 677671 Null 0.0421163101172308 0.22264402
NSC 679743 1,4,7,10,13,16-Hexaoxacyclooctadecane-2,9-dione, 12-[4-hydroxy-3,5-bis(1,1-dimethylethyl)phenyl]- 0.0421163101172308 0.053009723
NSC 683125 2-Ethoxy-6-(O-methyl)hydroxyiminoestra-1,3,5(10)-trien-3,17.beta.-diol 0.0421163101172308 0.24692166
NSC 683555 Camptothecin Derivative 0.0421163101172308 0.042523851
NSC 685106 Isopropyl 4-[2-[4-bromo-2,5-dihydroxyphenyl]ethyl]benzoate 0.0421163101172308 0.27365266
NSC 693324 Null 0.0421163101172308 -0.047776045
NSC 693334 Null 0.0421163101172308 0.22141891
NSC 696864 Null 0.0421163101172308 0.25779498
Total:115  Current:104    [First] [Prev] [Next] [Last]